BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Ding S. The biological and pharmacological connections between diabetes and various types of cancer. Pathol Res Pract 2021;227:153641. [PMID: 34619575 DOI: 10.1016/j.prp.2021.153641] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Memon AA, Vats S, Sundquist J, Li Y, Sundquist K. Mitochondrial DNA Copy Number: Linking Diabetes and Cancer. Antioxid Redox Signal 2022;37:1168-90. [PMID: 36169625 DOI: 10.1089/ars.2022.0100] [Reference Citation Analysis]
2 Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Bradu P, Sukumar A, Patil M, Renu K, Dey A, Vellingiri B, George A, Ganesan R. Implications of cancer stem cells in diabetes and pancreatic cancer. Life Sci 2022;312:121211. [PMID: 36414089 DOI: 10.1016/j.lfs.2022.121211] [Reference Citation Analysis]
3 Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Yamamoto A, Takahashi K, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Oyamada S, Kobayashi N, Aishima S, Saito S, Nakajima A, Yoneda M. Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease. JGH Open 2022. [DOI: 10.1002/jgh3.12808] [Reference Citation Analysis]
4 Nwabo Kamdje AH, Seke Etet PF, Kipanyula MJ, Vecchio L, Tagne Simo R, Njamnshi AK, Lukong KE, Mimche PN. Insulin-like growth factor-1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential. Front Endocrinol 2022;13:927390. [DOI: 10.3389/fendo.2022.927390] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bao X, Xu B, Muhammad IF, Nilsson PM, Nilsson J, Engström G. Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality. Diabetologia 2022. [PMID: 35922613 DOI: 10.1007/s00125-022-05771-w] [Reference Citation Analysis]
6 Wu H, Huang D, Zhou H, Sima X, Wu Z, Sun Y, Wang L, Ruan Y, Wu Q, Wu F, She T, Chu Y, Huang Q, Ning Z, Zhang H. Metformin: A promising drug for human cancers. Oncol Lett 2022;24:204. [PMID: 35720480 DOI: 10.3892/ol.2022.13325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]